Menu Back toInstructors

Short Course 1: The Evolving Landscape of Real-World Data (RWD) and the Use of Pharmacoepidemiologic Methods and Machine Learning to Generate Credible Real-World Evidence (RWE)


  • Gillis  Carrigan, PhD, MS

    Gillis Carrigan, PhD, MS

    • Director, Center for Observational Research
    • Amgen, United States

    Dr. Carrigan has over 20 years of experience in observational studies with a focus on study design and methodology. He is experienced with the use of electronic medical records (EMR), administrative claims data, and registry data. He has worked with observational data in a number of settings and therapeutic areas including oncology, neuroscience, respiratory disease, and vaccine safety. In recent years, he has focused on applying epidemiological methods to real-world oncology data to augment evidence from clinical trials.

  • Carrie  Nielson, PhD, MPH

    Carrie Nielson, PhD, MPH

    • Observational Research Senior Manager
    • Amgen, United States

    Carrie focuses on design and analytic methods for RWD in the Center for Observational Research at Amgen. Her experience includes descriptive and comparative effectiveness studies to support new indications, label expansion applications, and post-marketing drug utilization and comparative safety studies. In the Center for Observational Research, she guides innovative study designs and analytic methods to combat confounding, time-related biases, and misclassification of exposures and outcomes.

  • Dorothee B Bartels, PhD, MSc

    Dorothee B Bartels, PhD, MSc

    • Head of Global Real World Evidence and Digital Science
    • UCB, Germany

    Dorothee joined UCB from X, Moonshot (Alphabet Inc.), where she was Clinical and Real World Data Strategy Lead. Prior she was 12 years with Boehringer Ingelheim as Corporate Head of Global Epidemiology and then Chief Digital Science Officer in the innovation Lab, Bi X. She maintains appointments as Associate Professor for Public Health and Epidemiology at Hannover Medical School (MHH) and as Adjunct Professor for Epidemiology and Biostatistics at McGill University. She is a fellow of the International Society of Pharmacoepidemiology and founder and immediate past chair of the Special Interest Group Digital Epidemiology.

  • Harriet  Dickinson, PhD

    Harriet Dickinson, PhD

    • RWE Innovation and Women’s Health Lead
    • UCB Biosciences GmbH, United Kingdom

Contact us

Customer Service


Return to

Real-World Evidence Conference